See more : Yamazaki Co., Ltd. (6147.T) Income Statement Analysis – Financial Results
Complete financial analysis of LHC Group, Inc. (LHCG) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of LHC Group, Inc., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- Schlumberger Limited (SLB.PA) Income Statement Analysis – Financial Results
- Gati Limited (GATI.NS) Income Statement Analysis – Financial Results
- Strip Tinning Holdings plc (STG.L) Income Statement Analysis – Financial Results
- Canada Nickel Company Inc. (CNC.V) Income Statement Analysis – Financial Results
- Sanbase Corporation Limited (8501.HK) Income Statement Analysis – Financial Results
LHC Group, Inc. (LHCG)
About LHC Group, Inc.
LHC Group, Inc., a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. It operates through five segments: Home Health Services, Hospice Services, Home and Community-Based Services, Facility-Based Services, and Healthcare Innovations (HCI). The Home Health Services segment offers skilled nursing, medically oriented social services and physical, occupational, and speech therapy. The Hospice Services segment provides pain and symptom management accompanied by palliative medication, emotional and spiritual support, inpatient and respite care, homemaker services, dietary counseling, family bereavement counseling, and social worker visits. Its Home and Community-Based Services segment offers range of services, such as assistance with grooming, medication reminders, meal preparation, assistance with feeding, light housekeeping, respite care, transportation, and errand. The Facility-Based Services segment treats patients with severe medical conditions who require a high-level of care and frequent monitoring by physicians and other clinical personnel. This segment serves patients suffering from respiratory failure, neuromuscular and cardiac disorders, non-healing wounds, renal disorders, cancer, head and neck injuries, and mental disorders, as well as treats patients diagnosed with musculoskeletal impairments; and operates nursing facilities, family health center, rural health clinic, and physician practice, as well as offers physical therapy services. The HCI segment provides strategic health management services to accountable care organizations. As of December 31, 2021, it operated 557 home health services locations, 170 hospice locations, 136 community-based service locations, 11 long-term acute care hospitals with 12 locations, and 14 HCI locations. The company was founded in 1994 and is based in Lafayette, Louisiana.
Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 2.28B | 2.22B | 2.06B | 2.08B | 1.81B | 1.07B | 914.82M | 816.37M | 733.63M | 658.28M | 637.57M | 633.87M | 635.03M | 531.98M | 383.30M | 298.03M | 215.25M | 162.55M | 122.98M | 68.52M | 47.37M | 28.21M |
Cost of Revenue | 1.40B | 1.34B | 1.25B | 1.32B | 1.16B | 675.81M | 557.65M | 480.88M | 434.78M | 383.46M | 365.75M | 352.35M | 329.99M | 270.52M | 186.85M | 152.58M | 109.85M | 88.34M | 63.25M | 34.46M | 22.22M | 13.47M |
Gross Profit | 883.61M | 883.01M | 812.80M | 755.35M | 653.61M | 396.28M | 357.17M | 335.49M | 298.86M | 274.82M | 271.82M | 281.53M | 305.05M | 261.47M | 196.45M | 145.45M | 105.40M | 74.21M | 59.73M | 34.06M | 25.15M | 14.74M |
Gross Profit Ratio | 38.71% | 39.78% | 39.40% | 36.31% | 36.11% | 36.96% | 39.04% | 41.10% | 40.74% | 41.75% | 42.63% | 44.41% | 48.04% | 49.15% | 51.25% | 48.80% | 48.97% | 45.65% | 48.57% | 49.71% | 53.10% | 52.26% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 741.10M | 675.52M | 632.85M | 596.01M | 537.92M | 310.54M | 270.62M | 248.63M | 233.95M | 214.13M | 205.64M | 275.59M | 201.84M | 171.70M | 136.16M | 106.80M | 71.13M | 53.74M | 0.00 | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 741.10M | 675.52M | 632.85M | 596.01M | 537.92M | 310.54M | 270.62M | 248.63M | 233.95M | 214.13M | 205.64M | 275.59M | 201.84M | 171.70M | 136.16M | 106.80M | 71.13M | 53.74M | 0.00 | 0.00 | 0.00 | 0.00 |
Other Expenses | 23.14M | 20.92M | 0.00 | 0.00 | 0.00 | 9.48M | 14.79M | 19.24M | 15.78M | 13.93M | 11.88M | 12.32M | 7.61M | 4.72M | 0.00 | 0.00 | 0.00 | 0.00 | 39.71M | 24.31M | 15.90M | 11.12M |
Operating Expenses | 764.24M | 696.44M | 632.85M | 596.01M | 537.92M | 320.02M | 285.41M | 267.87M | 249.73M | 228.06M | 217.51M | 287.91M | 209.44M | 176.42M | 136.16M | 106.80M | 71.13M | 53.74M | 39.71M | 24.31M | 15.90M | 11.12M |
Cost & Expenses | 2.16B | 2.03B | 1.88B | 1.92B | 1.69B | 995.83M | 843.06M | 748.75M | 684.50M | 611.53M | 583.26M | 640.25M | 539.43M | 446.93M | 323.01M | 259.37M | 180.98M | 142.08M | 102.96M | 58.76M | 38.12M | 24.59M |
Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 31.31M | 4.34M | 4.13M | 11.16M | 9.68M | 3.88M | 2.94M | 2.30M | 2.49M | 2.00M | 1.55M | 1.02M | 134.00K | 142.00K | 469.00K | 376.00K | 325.00K | 1.07M | 1.19M | 1.22M | 1.13M | 411.00K |
Depreciation & Amortization | 64.19M | 58.42M | 55.80M | 51.62M | 16.36M | 13.42M | 12.16M | 11.96M | 9.57M | 8.33M | 7.81M | 7.52M | 7.50M | 4.83M | 3.74M | 3.03M | 2.43M | 1.75M | 1.02M | -3.29M | -3.02M | -2.42M |
EBITDA | 152.33M | 216.18M | 178.11M | 151.61M | 112.01M | 78.35M | 73.86M | 69.44M | 48.41M | 48.52M | 54.31M | -6.67M | 95.60M | 89.53M | 60.29M | 38.66M | 33.76M | 20.47M | 17.13M | 6.47M | 6.23M | 1.20M |
EBITDA Ratio | 6.67% | 9.74% | 10.06% | 8.90% | 6.19% | 7.31% | 8.07% | 8.51% | 6.60% | 7.37% | 8.52% | -1.05% | 13.88% | 16.83% | 13.86% | 11.79% | 15.69% | 11.25% | 13.93% | 9.44% | 13.16% | 4.25% |
Operating Income | 88.14M | 182.24M | 178.11M | 151.61M | 111.00M | 74.68M | 70.56M | 66.34M | 45.49M | 46.76M | 54.31M | -6.38M | 95.60M | 85.05M | 60.29M | 38.66M | 34.27M | 20.47M | 20.02M | 9.75M | 9.25M | 3.62M |
Operating Income Ratio | 3.86% | 8.21% | 8.63% | 7.29% | 6.13% | 6.97% | 7.71% | 8.13% | 6.20% | 7.10% | 8.52% | -1.01% | 15.05% | 15.99% | 15.73% | 12.97% | 15.92% | 12.59% | 16.28% | 14.24% | 19.53% | 12.83% |
Total Other Income/Expenses | -31.31M | -937.00K | -4.13M | -11.16M | -9.68M | -3.35M | -2.44M | -1.85M | -2.22M | -1.75M | -1.37M | 763.00K | 671.00K | -403.00K | -11.36M | -6.92M | -3.26M | -473.00K | -5.39M | -1.12M | -1.01M | -86.00K |
Income Before Tax | 77.21M | 181.30M | 173.98M | 140.46M | 101.32M | 71.33M | 68.12M | 64.50M | 43.27M | 45.01M | 52.94M | -5.62M | 96.27M | 84.64M | 61.26M | 39.36M | 35.98M | 19.99M | 14.63M | 8.64M | 8.25M | 3.53M |
Income Before Tax Ratio | 3.38% | 8.17% | 8.43% | 6.75% | 5.60% | 6.65% | 7.45% | 7.90% | 5.90% | 6.84% | 8.30% | -0.89% | 15.16% | 15.91% | 15.98% | 13.21% | 16.72% | 12.30% | 11.90% | 12.61% | 17.40% | 12.53% |
Income Tax Expense | 16.96M | 37.69M | 36.04M | 26.61M | 22.40M | 10.94M | 22.18M | 22.85M | 14.51M | 15.86M | 17.51M | -1.97M | 31.73M | 26.74M | 18.73M | 12.15M | 10.42M | 5.36M | 5.61M | 2.40M | 2.26M | 2.75M |
Net Income | 60.25M | 143.62M | 111.60M | 95.73M | 63.57M | 50.11M | 36.58M | 32.34M | 21.84M | 22.34M | 27.44M | -13.24M | 48.80M | 57.81M | 30.20M | 19.59M | 20.59M | 10.10M | 9.31M | 2.84M | 2.84M | 787.00K |
Net Income Ratio | 2.64% | 6.47% | 5.41% | 4.60% | 3.51% | 4.67% | 4.00% | 3.96% | 2.98% | 3.39% | 4.30% | -2.09% | 7.68% | 10.87% | 7.88% | 6.57% | 9.57% | 6.21% | 7.57% | 4.15% | 6.00% | 2.79% |
EPS | 1.97 | 4.57 | 3.56 | 3.07 | 2.29 | 2.83 | 2.08 | 1.86 | 1.27 | 1.31 | 1.54 | -0.73 | 2.69 | 3.22 | 1.69 | 1.10 | 1.20 | 0.69 | 0.77 | 0.24 | 0.24 | 0.07 |
EPS Diluted | 1.97 | 4.57 | 3.56 | 3.07 | 2.29 | 2.79 | 2.07 | 1.84 | 1.26 | 1.30 | 1.53 | -0.73 | 2.68 | 3.20 | 1.69 | 1.10 | 1.20 | 0.69 | 0.77 | 0.23 | 0.24 | 0.06 |
Weighted Avg Shares Out | 30.66M | 31.43M | 31.37M | 31.21M | 27.77M | 17.72M | 17.56M | 17.41M | 17.23M | 17.05M | 17.85M | 18.27M | 18.12M | 17.96M | 17.86M | 17.76M | 17.09M | 14.63M | 12.09M | 12.09M | 11.93M | 11.76M |
Weighted Avg Shares Out (Dil) | 30.66M | 31.43M | 31.37M | 31.21M | 27.77M | 17.96M | 17.68M | 17.55M | 17.32M | 17.13M | 17.90M | 18.27M | 18.23M | 18.07M | 17.90M | 17.83M | 17.10M | 14.68M | 12.15M | 12.11M | 12.08M | 12.24M |
LHC Group: A Deal That Could Go Through Unchallenged After All
Mergers and Acquisitions in 2023 Off To A Strong Start
GDRX or LHCG: Which Is the Better Value Stock Right Now?
LHC Group's (LHCG) Q3 Earnings & Revenues Miss Estimates
LHC Group (LHCG) Q3 Earnings and Revenues Lag Estimates
LHC Group announces third quarter 2022 financial results
LHC Group's (LHCG) Latest Tie-Up to Improve Patient Services
LHC Group and University of Maryland Medical System announce home health partnership
LHC Group to acquire home health provider in Georgia
LHC Group announces second quarter 2022 financial results
Source: https://incomestatements.info
Category: Stock Reports